Form D · Pharmaceuticals
Pharmaceutical Resource Technology, Inc.
Singapore, U0 · CIK 0001865759
Offering snapshot reported Mar 17, 2025 · SEC filing
- Reported sold
- Yet to sell Offering amount: $10M
- Investors reported
- 0 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Yet to occur As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Mar 17, 2025 | Initial | Yet to sell | No comparison | 0 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 04
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $1M (estimated)
- Finders' fees
- $1M (estimated)
- Form D file number
- 021-541041
Source: Form D, filed Mar 17, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No matching detailed fund disclosure was found in the latest imported ADV filings. This does not establish that the issuer has no adviser.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Hui Eng Ling | Director, Executive, Promoter |
| Jacksaa Tan | Director, Executive, Promoter |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
1 Kaki Bukit Ave 3, #09 11, Kb 1
Singapore, U0, 416087
Phone: 65 6841 0132
Singapore, U0, 416087
Phone: 65 6841 0132